Search Results 1331-1340 of 13315 for monoclonal antibody

  1. Clinical trials - Oncology (Medical)

    This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...

  2. Medical Research & Education - Mayo Clinic News Network

    Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...

  3. Medical Research & Education - Mayo Clinic News Network

    Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...

  4. Valemetostat Tosylate (DS-3201b), An Enhancer Of Zeste Homolog (EZH) 1/2 Dual Inhibitor, For Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01) - Mayo Clinic

    Prior systemic therapy (e.g., chemotherapy, immunomodulatory therapy, or monoclonal antibody therapy) within 3 weeks prior to the first dose of study drug; ...

  5. Clinical trials - Oncology (Medical)

    The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

  6. Medical Research & Education - Mayo Clinic News Network

    Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...

  7. Seroprevalence Study Of Pre-existing Immunity For Adenovirus-associated Virus Vector In MYBPC3-associated Hypertrophic Cardiomyopathy - Mayo Clinic

    Currently receiving systemic immunosuppressive therapy, cytotoxic chemotherapy, immunoglobulin therapy, or monoclonal antibody therapy. History of ...

  8. Clinical trials - Oncology (Medical)

    The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

  9. Trial To Assess Safety And Effectiveness Of MOR202 In Anti-PLA2R + Membranous Nephropathy (AMN) - Mayo Clinic

    ... antibody MOR202 in adult subjects with in Anti-PLA2R Antibody Positive Membranous Nephropathy (newly diagnosed/relapsed/refractory). Participation ...

  10. Medical Research & Education - Mayo Clinic News Network

    Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...